First Debate: Should the Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip?

• Absolutely – As Long as He Receives Truly Informed Consent by a Heart Team!
  Brian Whisenant, MD 
   
• Absolutely Not – In No Universe Would That Be Considered Acceptable Care!
  Alfredo Trento, MD 
   
• Roundtable Discussion
  Gregg W. Stone, MD, Michael Borger, MD, and Ori Ben-Yehuda, MD
   

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR?

• Transcatheter MV Replacement Will Become Standard of Care for Secondary MR!
  Stephan Windecker, MD   
   
• No, the Bar Is Too High – Transcatheter Mitral Repair Will Always Be Safer and Nearly as Effective!
  Ted Feldman, MD
   
• Surgical Mitral Valve Repair or Replacement via a Minimally Invasive Approach Will Be the Gold Standard!
  Steven Bolling, MD
   
• Roundtable Discussion 
  Gregg W. Stone, MD, Michael Borger, MD, and Ori Ben-Yehuda, MD

My Rosy Prophecy: What Will the Specialty of Mitral Valve Therapeutics Look Like in 10 Years?
Alec Vahanian, MD

Roundtable Discussion 
Gregg W. Stone, MD, Michael Borger, MD, and Ori Ben-Yehuda, MD